OVID Ovid Therapeutics Inc.

Fundamentals / CIK 0001636651 / USD

Ovid Therapeutics Inc. reported $1.45M in revenue and a net loss of $43.11M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -4700.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OVID in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$213.9M$107.0M$0-$93.48MFY 2016 Net Income: -$22.41M2016FY 2017 Net Income: -$64.81M2017FY 2018 Net Income: -$51.98M2018FY 2019 Net Income: -$60.46M2019FY 2020 Revenue: $12.62MFY 2020 Net Income: -$81.04M2020FY 2021 Revenue: $208.4MFY 2021 Net Income: $122.8M2021FY 2022 Revenue: $1.50MFY 2022 Net Income: -$54.17M2022FY 2023 Revenue: $392KFY 2023 Net Income: -$52.34M2023FY 2024 Revenue: $566KFY 2024 Net Income: -$26.43M2024FY 2025 Revenue: $7.25MFY 2025 Net Income: -$17.41M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $7.25M $566K $392K $1.50M $208.4M $12.62M -- -- -- --
Research & Development $25.58M $36.77M $28.59M $24.62M $46.94M $63.42M $42.16M $33.79M $49.97M $9.59M
Total Operating Expenses $49.69M $62.45M $59.67M $57.05M $84.17M $94.05M $61.41M $52.93M $65.01M $22.54M
Operating Income -$42.44M -$61.88M -$59.28M -$55.55M $124.2M -$81.43M -$61.41M -$52.93M -$65.01M -$22.54M
EBITDA -$42.17M -$61.27M -$58.71M -$55.04M $124.4M -$81.12M -$61.15M -$52.79M -$64.93M -$22.48M
Interest Income $2.03M $3.92M $4.94M -- -- -- -- -- -- --
Income Before Tax -$17.41M -$26.43M -$52.34M -$54.17M $124.2M -$81.04M -- -- -- --
Income Tax Expense $0 $0 $0 $0 $1.33M $0 $0 $0 $0 --
Net Income -$17.41M -$26.43M -$52.34M -$54.17M $122.8M -$81.04M -$60.46M -$51.98M -$64.81M -$22.41M
Basic EPS -- -- -$0.74 -$0.77 $1.78 -$1.39 -- -$2.11 -$3.35 -$2.28
Diluted EPS -- -- -$0.74 -$0.77 $1.76 -$1.39 -- -$2.11 -$3.35 -$2.28
Basic Shares Outstanding -- -- 70.6M 70.4M 67.5M 58.5M -- 24.6M 19.3M 9.8M
Diluted Shares Outstanding -- -- 70.6M 70.4M 68.1M 58.5M -- 24.6M 19.3M 9.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $733K $0 $718K $132K $6.27M $130K $76K
Research & Development $15.70M $9.96M $11.18M $6.59M $5.87M $6.46M $6.66M $5.92M
Total Operating Expenses $22.36M $16.43M $17.85M $13.01M $12.65M $11.35M $12.68M $10.80M
Operating Income -$22.36M -$15.70M -$17.85M -$12.29M -$12.52M -$5.07M -$12.55M -$10.72M
EBITDA -$22.35M -$15.68M -$17.81M -$12.28M -$12.51M -$4.97M -$12.41M -$10.56M
Interest Income $1.50M $1.56M $737K $847K $303K $384K $491K $650K
Income Before Tax -$20.78M -$15.01M -$16.99M $9.66M -$12.16M -$4.68M -$10.23M -$9.25M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$20.78M -$15.01M -$16.99M $9.66M -$12.16M -$4.68M -$10.23M -$9.25M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $13.15M $26.30M $27.04M $44.87M $187.8M $72.03M $41.90M $36.49M $87.13M $51.94M
Short-Term Investments $56.48M $26.77M $78.79M $84.13M $0 -- $34.84M $5.01M -- --
Cash & Short-Term Investments $90.45M $53.08M $105.8M $129.0M $187.8M $72.03M $76.70M $41.50M $87.13M $51.94M
Total Current Assets $74.37M $55.94M $109.6M $131.4M $190.5M $74.84M $79.81M $44.27M $88.59M $52.41M
Property, Plant & Equipment, Net $252K $433K $769K $1.15M $243K $136K $68K $70K $52K $44K
Intangible Assets $0 $100K $200K $222K $164K $319K $467K $392K $124K $110K
Long-Term Investments $20.81M $20.97M $17.63M $5.62M $1.63M $0 -- -- -- --
Other Non-Current Assets $0 $92K $210K $261K $260K $319K $467K $392K $124K $165K
Total Non-Current Assets $76.57M $36.23M $34.43M $23.89M $4.07M $1.08M $1.03M $3.38M $870K $617K
Total Assets $150.9M $92.17M $144.0M $155.3M $194.5M $75.93M $80.84M $47.65M $89.46M $53.03M
Accounts Payable $1.96M $3.19M $3.70M $1.95M $7.13M $5.45M $3.26M $3.76M $2.03M $857K
Deferred Revenue (Current) -- -- -- -- $0 $2.21M -- -- -- --
Total Current Liabilities $8.29M $10.52M $11.47M $6.99M $14.80M $22.06M $10.53M $8.84M $6.02M $3.73M
Deferred Revenue (Non-Current) -- -- -- -- $0 $10.17M -- -- -- --
Total Non-Current Liabilities $11.99M $13.42M $44.76M $16.00M $0 $10.23M $287K $0 $0 $0
Total Liabilities $20.27M $23.94M $56.23M $22.99M $14.80M $32.29M $10.82M $8.84M $6.02M $3.73M
Total Debt (incl. Leases) $13.42M $14.76M $16.00M $16.54M -- -- -- -- -- --
Common Stock $130K $71K $71K $70K $70K $66K $55K $25K $25K $9.8K
Retained Earnings -$321.7M -$304.3M -$277.9M -$225.5M -$171.4M -$294.2M -$213.2M -$152.7M -$100.7M -$35.91M
Accumulated Other Comp. Income -$202K -$35K $1.0K -$42K $0 -- $2.5K -$1.8K -- --
Total Stockholders' Equity $130.7M $68.23M $87.80M $132.3M $179.7M $43.63M $70.02M $38.81M $83.44M $49.29M
Total Equity $130.7M $68.23M $87.80M $132.3M $179.7M $43.63M $70.02M $38.81M $83.44M $49.29M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $13.81M $11.33M $94.06M $13.15M $20.61M $28.41M $21.14M $26.30M
Short-Term Investments $122.8M $105.9M $61.46M $56.48M $4.99M $9.93M $21.86M $26.77M
Cash & Short-Term Investments $161.4M $169.8M $165.6M $90.45M $25.60M $38.35M $43.00M $53.08M
Total Current Assets $142.0M $123.6M $160.1M $74.37M $28.82M $42.09M $45.92M $55.94M
Property, Plant & Equipment, Net $186K $201K $217K $252K $269K $285K $346K $433K
Intangible Assets $0 $0 $0 $0 $0 $0 $38K $100K
Long-Term Investments $24.82M $52.55M $10.08M $20.81M $20.91M $20.91M $20.91M $20.97M
Other Non-Current Assets -- -- -- $0 $0 $0 $39K $92K
Total Non-Current Assets $80.29M $108.4M $65.48M $76.57M $35.02M $35.34M $35.73M $36.23M
Total Assets $222.2M $232.0M $225.6M $150.9M $63.85M $77.43M $81.65M $92.17M
Accounts Payable $5.86M $4.07M $8.88M $1.96M $1.71M $3.95M $1.95M $3.19M
Total Current Liabilities $11.86M $9.98M $15.75M $8.29M $6.80M $8.92M $9.31M $10.52M
Total Non-Current Liabilities $11.71M $12.10M $11.61M $11.99M $12.35M $12.71M $13.07M $13.42M
Total Liabilities $23.57M $22.08M $27.36M $20.27M $19.15M $21.64M $22.38M $23.94M
Total Debt (incl. Leases) $12.35M $12.71M $13.07M $13.42M $13.76M $14.10M $14.43M $14.76M
Common Stock $189K $185K $167K $130K $71K $71K $71K $71K
Retained Earnings -$374.5M -$353.7M -$338.7M -$321.7M -$331.4M -$319.2M -$314.5M -$304.3M
Accumulated Other Comp. Income -$1.03M -$750K -$422K -$202K -$126K -$69K -$47K -$35K
Total Stockholders' Equity $198.7M $209.9M $198.3M $130.7M $44.70M $55.79M $59.28M $68.23M
Total Equity $198.7M $209.9M $198.3M $130.7M $44.70M $55.79M $59.28M $68.23M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$17.41M -$26.43M -$52.34M -$54.17M $122.8M -$81.04M -$60.46M -$51.98M -$64.81M -$22.41M
Depreciation & Amortization $273K $613K $568K $513K $237K $307K $255K $142K $80K $57K
Stock-Based Compensation $4.81M $6.28M $7.29M $6.56M $5.05M $7.53M $5.21M $7.06M $6.40M $3.64M
Change in Payables -$1.23M -$512K $1.75M -$5.17M $1.70M $2.33M -$654K $1.65M $1.08M $187K
Operating Cash Flow -$38.33M -$55.96M -$45.78M -$55.23M $118.6M -$51.58M -$51.09M -$45.56M -$31.47M -$17.80M
Capital Expenditure $0 -$71K -$40K -$1.22M -$184K -$127K -$57K -$34K -$39K -$30K
Free Cash Flow -$38.33M -$56.03M -$45.82M -$56.45M $118.4M -$51.71M -$51.15M -$45.59M -$31.51M -$17.83M
Purchases of Investments -$91.85M -$73.25M -$112.4M -$173.0M $0 -$9.96M -$34.80M -$50.01M -- --
Investing Cash Flow -$49.85M $54.59M -$2.58M -$87.88M -$1.82M $34.65M -$30.04M -$5.36M -$47K -$189K
Common Stock Issued -- -- -- -- $0 $46.73M $64.12M -- -- --
Financing Cash Flow $75.21M $622K $30.54M $181K $904K $47.07M $86.54M $286K $66.70M -$14K
Net Change in Cash -$13.15M -$740K -$17.83M -$142.9M $117.7M $30.14M $5.41M -$50.64M $35.19M -$18.00M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$20.78M -$15.01M -$16.99M $9.66M -$12.16M -$4.68M -$10.23M -$9.25M
Depreciation & Amortization $15K $16K $35K $17K $16K $99K $141K $160K
Stock-Based Compensation $1.28M $1.43M $1.05M $1.20M $1.11M $1.22M $1.28M $1.26M
Change in Payables $1.78M -$1.51M $3.62M $246K -$2.24M $2.00M -$1.24M $481K
Operating Cash Flow -$15.88M -$17.59M -$13.90M -$10.41M -$12.87M -$4.77M -$10.28M -$10.01M
Capital Expenditure -- -- -- $0 $0 $0 $0 -$22K
Free Cash Flow -- -- -- -$10.41M -$12.87M -$4.77M -$10.28M -$10.03M
Purchases of Investments -$3.85M -$102.7M -$4.05M -$77.06M -$4.95M -$4.95M -$4.90M -$16.71M
Investing Cash Flow $11.15M -$86.74M $5.95M -$72.06M $5.05M $12.05M $5.10M $21.29M
Common Stock Issued $8.12M $1.0K $2.37M -- $0 $0 $0 --
Financing Cash Flow $7.28M $21.60M $88.98M $75.18M $15K $0 $13K $0
Net Change in Cash $2.48M -$82.74M $80.91M -$7.46M -$7.80M $7.28M -$5.17M $11.28M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -585.2% -10933.7% -15122.7% -3696.4% 59.6% -645.4% -- -- -- --
Net Profit Margin -240.1% -4670.1% -13351.8% -3604.7% 58.9% -642.3% -- -- -- --
Return on Equity (ROE) -13.3% -38.7% -59.6% -41.0% 68.3% -185.7% -86.3% -134.0% -77.7% -45.5%
Return on Assets (ROA) -11.5% -28.7% -36.3% -34.9% 63.1% -106.7% -74.8% -109.1% -72.4% -42.3%
Current Ratio 8.97x 5.32x 9.55x 18.79x 12.87x 3.39x 7.58x 5.01x 14.71x 14.04x
Quick Ratio 10.91x 5.04x 9.22x 18.45x 12.69x 3.26x 7.28x 4.69x 14.47x 13.91x
Debt to Equity 0.10x 0.22x 0.18x 0.13x -- -- -- -- -- --
Revenue Growth (YoY) +1181.3% +44.4% -73.9% -99.3% +1551.6% -- -- -- -- --
Operating Income Growth (YoY) -- -- -- -144.7% -- -- -- -- -- --
Net Income Growth (YoY) -- -- -- -144.1% -- -- -- -- -- --
EPS Growth (YoY) -- -- -- -143.3% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -146.6% -- -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -- -147.7% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -4700.3% -3686.7% -670.2% -585.2% -618.3% -625.0% -10404.2% -10933.2%
Net Profit Margin -2971.3% -2178.9% -339.3% -240.1% -549.6% -574.0% -4557.1% -4670.0%
Return on Equity (ROE) -21.7% -16.4% -12.2% -13.3% -81.3% -68.4% -42.1% -38.7%
Return on Assets (ROA) -19.4% -14.9% -10.7% -11.5% -56.9% -49.3% -30.6% -28.7%
Current Ratio 11.97x 12.39x 10.17x 8.97x 4.24x 4.72x 4.93x 5.32x
Quick Ratio 13.61x 17.01x 10.52x 10.91x 3.77x 4.30x 4.62x 5.04x
Debt to Equity 0.06x 0.06x 0.07x 0.10x 0.31x 0.25x 0.24x 0.22x
Revenue Growth (YoY) -100.0% -88.3% -100.0% +844.7% -23.7% +3611.2% -12.2% -46.5%
Net Income Growth (YoY) -- -- -- -- -- -155.0% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001636651) · from December 31, 2015 Data through September 30, 2026 · synced Nov 20, 2026, 05:35 UTC · Open in terminal